Tema Oncology ETF (NASDAQ:CANC) Short Interest Down 92.0% in February

Tema Oncology ETF (NASDAQ:CANCGet Free Report) saw a large drop in short interest in the month of February. As of February 15th, there was short interest totalling 1,300 shares, a drop of 92.0% from the January 31st total of 16,300 shares. Based on an average daily volume of 19,000 shares, the days-to-cover ratio is presently 0.1 days.

Tema Oncology ETF Price Performance

Shares of NASDAQ CANC opened at $25.64 on Friday. The firm has a 50-day moving average of $25.10 and a 200 day moving average of $27.00. Tema Oncology ETF has a 1 year low of $23.97 and a 1 year high of $30.11. The stock has a market cap of $65.38 million, a P/E ratio of 26.86 and a beta of 1.11.

Tema Oncology ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Thursday, December 12th. Shareholders of record on Wednesday, December 11th were paid a dividend of $0.7283 per share. The ex-dividend date was Wednesday, December 11th.

Institutional Inflows and Outflows

An institutional investor recently raised its stake in Tema Oncology ETF stock. Thrivent Financial for Lutherans lifted its stake in Tema Oncology ETF (NASDAQ:CANCFree Report) by 29.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 517,837 shares of the company’s stock after purchasing an additional 118,328 shares during the quarter. Thrivent Financial for Lutherans owned 20.31% of Tema Oncology ETF worth $13,156,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Tema Oncology ETF Company Profile

(Get Free Report)

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.

See Also

Receive News & Ratings for Tema Oncology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Oncology ETF and related companies with MarketBeat.com's FREE daily email newsletter.